Senile systemic amyloidosis, cerebral amyloid angiopathy, and dementia in a very old Finnish population

References

• Gustavsson A, Jahr H, Tobiassen R, Jacobson D R, Sletten K, Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 1995; 73: 703–708
   PubMed Web of Science ®Google Scholar
• Roher A, Wolfe D, Palutke M, KuKuruga D. Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 1986; 83: 2662–2666
   PubMed Web of Science ®Google Scholar
• Cohen A. Clinical aspects of amyloidosis, including related proteins and central nervous system amyloid. Curr Opin Rheumatol 1994; 6: 68–77
   PubMedGoogle Scholar
• Sipe J D. Amyloidosis. Annu Rev Biochem 1992; 61: 947–975
   PubMed Web of Science ®Google Scholar
• Pitkanen P, Westermark P, Cornwell G G, 3rd. Senile systemic amyloidosis. Am J Pathol 1984; 117: 391–399
   PubMed Web of Science ®Google Scholar
• Cornwell G G, 3rd, Murdoch W L, Kyle R A, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983; 75: 618–623
   PubMed Web of Science ®Google Scholar
• Johansson B, Westermark P. Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991; 32: 83–92
   PubMed Web of Science ®Google Scholar
• Olson L J, Gertz M A, Edwards W D, Li C Y, Pellikka P A, Holmes D R, Jr, Tajik A J, Kyle R A. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. New Engl J Med 1987; 317: 738–742
   PubMed Web of Science ®Google Scholar
• Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton J L. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003; 62: 885–898
   PubMed Web of Science ®Google Scholar
• Vinters H V, Wang Z Z, Secor D L. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996; 6: 179–195
   PubMed Web of Science ®Google Scholar
• Glenner G G, Wong C W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885–890
   PubMed Web of Science ®Google Scholar
• Olichney J M, Hansen L A, Hofstetter C R, Lee J H, Katzman R, Thal L J. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer's disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol 2000; 57: 869–874
   PubMedGoogle Scholar
• Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357: 169–175
   PubMed Web of Science ®Google Scholar
• Pfeifer L A, White L R, Ross G W, Petrovitch H, Launer L J. Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study. Neurology 2002; 58: 1629–1634
   PubMed Web of Science ®Google Scholar
• Tanskanen M, Lindsberg P J, Tienari P J, Polvikoski T, Sulkava R, Verkkoniemi A, Rastas S, Paetau A, Kiuru-Enari S. Cerebral amyloid angiopathy in a 95+ cohort: Complement activation and apolipoprotein E (APOE) genotype. Neuropathol Appl Neurobiol 2005; 31: 589–599
   PubMed Web of Science ®Google Scholar
• Ellis R J, Olichney J M, Thal L J, Mirra S S, Morris J C, Beekly D, Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV. Neurology 1996; 46: 1592–1596
   PubMed Web of Science ®Google Scholar
• Schmechel D E, Saunders A M, Strittmatter W J, Crain B J, Hulette C M, Joo S H, Pericak-Vance M A, Goldgaber D, Roses A D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 9649–9653
   PubMed Web of Science ®Google Scholar
• Greenberg S M, Rebeck G W, Vonsattel J P, Gomez-Isla T, Hyman B T. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995; 38: 254–259
   PubMed Web of Science ®Google Scholar
• Premkumar D R, Cohen D L, Hedera P, Friedland R P, Kalaria R N. Apolipoprotein E-epsilon 4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996; 148: 2083–2095
   PubMed Web of Science ®Google Scholar
• Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Systemic amyloid deposition in old age and dementia of Alzheimer's type: The relationship of brain amyloid to other amyloid. Acta Neuropathol (Berlin) 1988; 77: 136–141
   PubMed Web of Science ®Google Scholar
• Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology 2000; 20: 8–22
   PubMed Web of Science ®Google Scholar
• Yamada M. Risk factors for cerebral amyloid angiopathy in the elderly. Ann NY Acad Sci 2002; 977: 37–44
   PubMed Web of Science ®Google Scholar
• Masuda J, Tanaka K, Ueda K, Omae T. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 1988; 19: 205–210
   PubMed Web of Science ®Google Scholar
• Xu D, Yang C, Wang L. Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study. Acta Neuropathol (Berlin) 2003; 106: 89–91
   PubMed Web of Science ®Google Scholar
• Uno H, Alsum P B, Dong S, Richardson R, Zimbric M L, Thieme C S, Houser W D. Cerebral amyloid angiopathy and plaques, and visceral amyloidosis in aged macaques. Neurobiol Aging 1996; 17: 275–281
   PubMed Web of Science ®Google Scholar
• Uchida K, Nakayama H, Goto N. Pathological studies on cerebral amyloid angiopathy, senile plaques and amyloid deposition in visceral organs in aged dogs. J Vet Med Sci 1991; 53: 1037–1042
   PubMed Web of Science ®Google Scholar
• Sulkava R, Kainulainen K, Verkkoniemi A, Niinistö L, Sobel E, Davanipour Z, Polvikoski T, Haltia M, Kontula K. APOE Alleles in Alzheimer's Disease and Vascular Dementia in a Population Aged 85+. Neurobiol Aging 1996; 17: 373–376
   PubMed Web of Science ®Google Scholar
• Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. New Engl J Med 1995; 333: 1242–1247
   PubMed Web of Science ®Google Scholar
• Mirra S S, Heyman A, McKeel D, Sumi S M, Crain B J, Brownlee L M, Vogel F S, Hughes J P, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479–486
   PubMed Web of Science ®Google Scholar
• Mirra S S, Hart M N, Terry R D. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med 1993; 117: 132–144
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berlin) 1991; 82: 239–259
   PubMed Web of Science ®Google Scholar
• Polvikoski T, Sulkava R, Myllykangas L, Notkola I L, Niinisto L, Verkkoniemi A, Kainulainen K, Kontula K, Perez-Tur J, Hardy J, Haltia M. Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology 2001; 56: 1690–1696
   PubMed Web of Science ®Google Scholar
• Vinters H V, Gilbert J J. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983; 14: 924–928
   PubMed Web of Science ®Google Scholar
• Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987; 234: 371–376
   PubMed Web of Science ®Google Scholar